Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion type Assertion NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_head.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion description "[We engineered the human NSCLC cell line PC-9 (MET-positive cells harboring an exon 19 deletion of EGFR) to overexpress hHGF and evaluated the effects of an onartuzumab and erlotinib combination in vitro and in vivo in xenograft models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion evidence source_evidence_literature NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion SIO_000772 25522765 NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion wasDerivedFrom befree-2016 NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion wasGeneratedBy ECO_0000203 NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.